DHC — Diversified Healthcare Trust

DHC Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: $379.6 million
• Adjusted EBITDAre: $72.4 million
• Normalized FFO: $21.8 million ($0.09 per share)
• Consolidated NOI Growth: 31.3% year-over-year
• SHOP NOI for Q4: $38.3 million, up 27.6% from the previous year
• Full Year SHOP NOI: $139.3 million, at the high end of guidance
• Same Property Occupancy: Increased 90 basis points year-over-year to 82.4%
• Average Monthly Rate: Increased 5.8%
• Net Debt to Adjusted EBITDA: Reduced from 11.2x to 8.1x
• Liquidity: Approximately $255 million, including $105 million in unrestricted cash

2. Strategic Updates and Business Highlights

• Completed over $1.4 billion in capital markets activity, focusing on financing and asset sales.
• Transitioned 116 communities to seven operators, enhancing operational efficiency.
• Renovated over 30 communities, contributing to improved financial performance.
• Initiatives to drive occupancy and NOI include advanced CRM platforms, dynamic pricing strategies, and introducing differentiated care levels.
• Identified potential to add approximately 500 SHOP units through the reopening of underutilized areas, with expected ROI in the mid-teens.

3. Forward Guidance and Outlook

• 2026 SHOP NOI Guidance: Expected to be between $175 million and $185 million.
• Medical Office and Life Science NOI Guidance: Expected between $94 million and $98 million.
• Triple Net Lease NOI Guidance: Expected between $28 million and $30 million.
• Adjusted EBITDAre Guidance for 2026: Between $290 million and $305 million.
• Normalized FFO Guidance: Expected between $0.52 and $0.58 per share.
• Anticipated continued growth in occupancy and NOI margins, with a focus on operational improvements.

4. Bad News, Challenges, or Points of Concern

• The transition of communities to new operators may create operational challenges in the short term, although these are expected to dissipate.
• Decline in Medical Office and Life Science NOI due to property sales, with expected lower contributions from these segments in 2026.
• Potential risks related to the integration of new operators and the impact of external market conditions on occupancy and pricing.

5. Notable Q&A Insights

• Management emphasized a focus on organic growth through operational improvements rather than pursuing external acquisitions at this time.
• The cadence of NOI growth is expected to be back-loaded in 2026, with significant contributions anticipated in the latter half of the year.
• The company is considering the reopening of closed wings in existing communities, which could add units and enhance revenue, with costs estimated between $125 million and $175 million per unit.
• No immediate plans to address the dividend, with management focused on operational growth and improving financial metrics.

This summary encapsulates the key financial performance, strategic initiatives, future outlook, and challenges faced by DHC as discussed in the Q4 2025 earnings call.